Today: 9 June 2026
Nasdaq ends 2025 on a down note; markets closed today as jobs report, CPI loom
1 January 2026
2 mins read

Nasdaq ends 2025 on a down note; markets closed today as jobs report, CPI loom

NEW YORK, January 1, 2026, 08:07 ET — Market closed

  • Nasdaq Composite fell 0.8% on Wednesday to finish 2025 at 23,241.99, with trading shut on Thursday for New Year’s Day
  • A late-December pullback capped a strong year for big U.S. indexes, led by AI-linked optimism
  • Investors turn to Jan. 9 payrolls, Jan. 13 CPI and the start of bank earnings for the next market catalyst

U.S. stock markets are closed on Thursday for New Year’s Day after the Nasdaq Composite slipped 0.8% in the final session of 2025, ending at 23,241.99. The S&P 500 fell 0.7% to 6,845.50 and the Dow Jones Industrial Average lost 0.6% to 48,063.29.

The timing matters because the Nasdaq heads into 2026 near record territory after a year in which bets on artificial intelligence powered many of the biggest winners. The late-year dip is the first signal investors will test against hard data on inflation, the labor market and interest rates.

The first trading week of January also tends to bring deeper liquidity — more buyers and sellers, and fewer distortions from holiday-thinned flows. That makes the next session a quick read on whether year-end selling was housekeeping or a change in risk appetite.

Profit-taking weighed on tech and energy shares on Wednesday and extended a four-session Nasdaq slide, leaving the market without a traditional “Santa Claus rally,” a seasonal late-December and early-January lift. Microsoft fell 0.8% and EQT slipped 1.9%, while Vanda Pharmaceuticals jumped after the FDA approved its drug to prevent motion-induced vomiting; volume ran at 11.17 billion shares versus a 20-day average of 15.8 billion, Reuters reported. “I do not expect that the last few days will have so much bearing on the performance of the next year,” said Giuseppe Sette, co-founder and president of Reflexivity. Reuters

Even with Wednesday’s decline, the Nasdaq still finished 2025 up about one-fifth, reflecting a market that repeatedly leaned back into growth stocks after setbacks. That leaves valuations exposed to any surprise in rates or earnings once the calendar turns.

Investors have also treated the “AI trade” — shorthand for crowding into companies seen as key beneficiaries of artificial intelligence — as a long-duration bet. Those trades usually react fastest when Treasury yields rise, because higher yields can reduce the value of profits expected far in the future.

Before the next session, markets have a clear macro schedule to price. The U.S. employment report for December is scheduled for Jan. 9, followed by the December consumer price index on Jan. 13, according to the Bureau of Labor Statistics calendar.

The next Federal Reserve policy decision is set for Jan. 27-28, the Fed’s calendar shows, keeping rate expectations front and center for tech-heavy indexes like the Nasdaq.

Earnings are the other near-term swing factor, with big banks set to start reporting mid-month. JPMorgan Chase said it will discuss fourth-quarter results on Jan. 13, and Bank of America lists Jan. 14 as its next quarterly earnings release date.

From a technical standpoint, the Nasdaq ended the year a bit above the 23,000 mark, a round-number level many traders watch as an informal support zone. A quick break below it after the holiday could draw in short-term sellers, while a firm hold would suggest the pullback was contained.

Stock Market Today

  • Analysis Suggests SpaceX IPO May Be Overvalued
    June 8, 2026, 6:56 PM EDT. Despite optimistic projections, SpaceX's initial public offering (IPO) could be overvalued. Evaluations indicate that only the most ambitious 'Moonshot' scenario nearly matches the proposed IPO price, raising concerns about high market expectations. Investors should weigh potential risks given the optimistic forecasts underpinning the valuation.

Latest articles

T1 Energy Shares Dip After KORE Power Files New Update

T1 Energy Shares Dip After KORE Power Files New Update

9 June 2026
T1 Energy shares slid 3.2% to $9.13 after a new SEC filing revealed up to $24.7 million in stock-linked payments for its $32 million KORE Power acquisition, spotlighting dilution risks as the company expands into battery storage and data-center power; the deal’s structure and timing come as T1 seeks growth funding and investors weigh near-term costs against future EBITDA targets.
OpenAI IPO filing puts AI rally at center stage for Wall Street

OpenAI IPO filing puts AI rally at center stage for Wall Street

9 June 2026
OpenAI has confidentially filed for a possible IPO, but investors won’t see key financials—including revenue quality, cash burn, and compute costs—until the S-1 goes public; with $2 billion monthly revenue and a recent $852 billion valuation, the filing signals a pivotal shift as AI giants race for public capital amid rising infrastructure costs and growing competition from Anthropic.
Wall Street Volatility Index Jumps as Chip Stocks Swing

Wall Street Volatility Index Jumps as Chip Stocks Swing

9 June 2026
The VIX plunged 12% to 18.92 as chip stocks rebounded sharply, with the Philadelphia Semiconductor Index jumping 5.6% and Intel soaring 11.2% after a major Google order, clawing back part of Friday’s $1.3 trillion rout; investors remain cautious ahead of key inflation data, interest rate decisions, and Middle East risks.
UBS Puts $850 Target on Cummins as AI Data Center Wave Fuels Shares

UBS Puts $850 Target on Cummins as AI Data Center Wave Fuels Shares

9 June 2026
UBS upgraded Cummins to Buy and hiked its price target to $850 from $565, citing surging data-center backup power demand and a stronger North American truck cycle; Cummins shares jumped 3.3% to $672.68 as UBS projected 2028 EPS of $41.25, topping consensus, and flagged double-digit Power business growth and raised long-term targets as key drivers.
Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Previous Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop